	부채에 대한이자 비용		날짜
AbbVie	USD 645M	69M	2026-03
Amgen	USD 657M	4M	2026-03
Anika Therapeutics	179.39M	556.84M	2026-03
Arrowhead Research	USD 22.5M	811K	2025-12
AstraZeneca	USD 484M	181M	2025-12
BioCryst Pharmaceuticals	USD 14.14M	5.53M	2025-12
Biogen	USD 72.6M	12.6M	2025-06
Bristol-Myers Squibb	USD 411M	21M	2026-03
Enanta Pharmaceuticals	USD 1.96M	620K	2024-12
Gilead Sciences	USD 255M	1000K	2025-12
GlaxoSmithKline	GBP 167M	21M	2026-03
Halozyme Therapeutics	USD 4.91M	615K	2025-12
Heron Therapeutics	USD 600K	100K	2024-12
Immunic	197K	222K	2025-12
Incyte	USD 569K	13K	2026-03
Insmed	USD 20.6M	217K	2025-12
Ionis Pharmaceuticals	USD 17M	1000K	2026-03
J&J	USD 43M	25M	2026-03
Karyopharm Therapeutics	USD 12.62M	1.24M	2025-12
Ligand Pharmaceuticals	USD 910K	243K	2025-09
Merck	USD 479M	67M	2026-03
Neurocrine Biosciences	USD 1.1M	0	2024-03
Novartis	USD 343M	39M	2026-03
Novavax	USD 5.82M	342K	2025-12
Pfizer	USD 711M	59M	2025-12
PTC Therapeutics	USD 50.58M	2.59B	2025-12
Roche Holding	CHF 304M	7.5M	2025-06
Sarepta Therapeutics	USD 7.56M	2.33M	2025-09
Vertex Pharmaceuticals	USD 3.3M	0	2025-12